TY - JOUR
T1 - Undertreatment of tobacco use relative to other chronic conditions
AU - Bernstein, Steven L.
AU - Yu, Sunkyung
AU - Post, Lori A.
AU - Dziura, James
AU - Rigotti, Nancy A.
PY - 2013/8
Y1 - 2013/8
N2 - Objectives. We compared the likelihood that a tobacco user would receive treatment with the likelihood that an adult with another common chronic condition would receive treatment for that condition at an office visit. Methods. We analyzed data from the 2005-2007 National Ambulatory Medical Care Survey to compare the proportion of US office visits at which tobacco users and individuals with hypertension, hyperlipidemia, diabetes, asthma, or depression received condition-specific treatment. We calculated the odds that a visit for a comparison condition would result in treatment relative to a visit for tobacco dependence. Results. From 2005 to 2007, 38 004 patient visits involved at least 1 study condition. Tobacco users received medication at fewer visits (4.4%) than individuals with hypertension (57.4%), diabetes (46.2%), hyperlipidemia (47.1%), asthma (42.6%), and depression (53.3%). In multivariate analyses, the odds for pharmacological treatment of these disorders relative to tobacco use were, for hypertension, 32.8; diabetes, 20.9; hyperlipidemia, 16.5; asthma, 22.1; and depression, 24.0 (all Ps < .001). Patients with hypertension, diabetes, or hyperlipidemia were also more likely to receive behavioral counseling. Conclusions. Alternate models of engagement may be needed to enhance use of effective treatments for tobacco use.
AB - Objectives. We compared the likelihood that a tobacco user would receive treatment with the likelihood that an adult with another common chronic condition would receive treatment for that condition at an office visit. Methods. We analyzed data from the 2005-2007 National Ambulatory Medical Care Survey to compare the proportion of US office visits at which tobacco users and individuals with hypertension, hyperlipidemia, diabetes, asthma, or depression received condition-specific treatment. We calculated the odds that a visit for a comparison condition would result in treatment relative to a visit for tobacco dependence. Results. From 2005 to 2007, 38 004 patient visits involved at least 1 study condition. Tobacco users received medication at fewer visits (4.4%) than individuals with hypertension (57.4%), diabetes (46.2%), hyperlipidemia (47.1%), asthma (42.6%), and depression (53.3%). In multivariate analyses, the odds for pharmacological treatment of these disorders relative to tobacco use were, for hypertension, 32.8; diabetes, 20.9; hyperlipidemia, 16.5; asthma, 22.1; and depression, 24.0 (all Ps < .001). Patients with hypertension, diabetes, or hyperlipidemia were also more likely to receive behavioral counseling. Conclusions. Alternate models of engagement may be needed to enhance use of effective treatments for tobacco use.
UR - http://www.scopus.com/inward/record.url?scp=84880147998&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880147998&partnerID=8YFLogxK
U2 - 10.2105/AJPH.2012.301112
DO - 10.2105/AJPH.2012.301112
M3 - Article
C2 - 23763395
AN - SCOPUS:84880147998
SN - 0090-0036
VL - 103
SP - e59-e65
JO - American journal of public health
JF - American journal of public health
IS - 8
ER -